Intellectual Property India Publishes Patent Application for 'Pseudovirus Based Neutralization Assay For Evaluating Vaccine Immunogenicity' Filed by Novavax, Inc.

MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517012305 A) filed by Novavax, Inc., Gaithersburg, U.S.A., on Feb. 13, for 'pseudovirus based neutralization assay for evaluating vaccine immunogenicity.'

Inventor(s) include Cai, Zhaohui; and Kalkeri, Raj.

The application for the patent was published on April 18, under issue no. 16/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are pseudoviruses expressing a SARS-CoV-2 S glycoprotein. Also provided herein are assays that employ the pseudoviruses to evaluate the immunogenicity of a biological sample against a SARS-CoV-2 virus or variant thereof. Also provided herein are methods of evaluating the imm...